View Single Post
Old 06-06-2007, 08:20 AM   #2
Hopeful
Senior Member
 
Join Date: Aug 2006
Posts: 3,380
Thanks for posting, Christine. I am a little confused about the ending of the article, which reads:

"Interestingly, Perez also found that estrogen-receptor-positive tumors experienced a 15 percent improvement, even though many physicians had believed these tumors did not respond well to Herceptin.

'That's going to be news to a lot of people,' Perez said."

I wasn't aware that there was a question about the efficacy of Herceptin in Her2+/ER+ patients, and don't know what the "15% improvement" refers to.
Does anyone know?

Hopeful
Hopeful is offline   Reply With Quote